10.04.2017Catabasis Pharmaceuticals Reports Positive Results From Open-Label Extension Of Phase 2 MoveDMD®
10.04.2017AVROBIO, Inc. Expands Rare Disease Pipeline with Gene Therapy to Treat Cystinosis
More News >